Search Results - "Dragovic, G."

The metabolic syndrome, an epidemic among HIV-infected patients on HAART by Jevtović, Dj, Dragović, G, Salemović, D, Ranin, J, Djurković-Djaković, O

“…Summary Background HAART has dramatically changed the prognosis of AIDS, but has led to long-term toxicities of antiretroviral drugs. A major chronic…”
Get full text

The prevalence and risk of hepatitis flares in a Serbian cohort of HIV and HCV co-infected patients treated with HAART by Jevtović, Dj, Ranin, J, Salemović, D, Pešić, I, Dragović, G, Žerjav, S, Djurković-Djaković, O

“…Abstract Despite substantial benefits of HAART treatment of HIV-infected patients, cumulative long-term toxicity, including drug-induced hepatotoxicity, has…”
Get full text

Incidence of acute pancreatitis and nucleoside reverse transcriptase inhibitors usage by Dragovic, G, Milic, N, Jevtovic, D J

“…Acute pancreatitis (AP) is a well-known adverse effect of nucleoside reverse transcriptase inhibitors (NRTIs). Therefore, we performed a prospective, cohort…”
Get more information

Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents by Byonanebye, DM, Polizzotto, MN, Begovac, J, Grabmeier-Pfistershammer, K, Abela, I, Castagna, A, De Wit, S, Mussini, C, Vehreschild, JJ, Monforte, AD, Wit, FWNM, Pradier, C, Chkhartishvili, N, Sonnerborg, A, Hoy, J, Lundgren, J, Neesgaard, B, Bansi-matharu, L, Greenberg, L, Llibre, JM, Vannappagari, V, Gallant, J, Necsoi, C, Cichon, P, Reiss, P, Aho, I, Tsertsvadze, T, Mennozzi, M, Rauch, A, Muccini, C, Law, M, Mocroft, A, Ryom, L, Petoumenos, K

“…To compare the incidence of dyslipidemia in people with HIV receiving integrase inhibitors (INSTI) versus boosted protease inhibitors (PI/b) and nonnucleoside…”
Get full text

Acute pancreatitis in HIV/AIDS patients:an issue of concern by Dragovic, Gordana

“…Pancreatitis is a well-described complication of human immunodeficiency virus(HIV)itself and its comhinalion antiretroviral therapy.Historically,this has been…”
Get full text

Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment by Mocroft, Amanda, Lundgren, Jens, Gerstoft, Jan, Rasmussen, Line D, Bhagani, Sanjay, Aho, Inka, Pradier, Christian, Bogner, Johannes R, Mussini, Christina, Uberti Foppa, Caterina, Maltez, Fernando, Laguno, Montse, Wandeler, Gilles, Falconer, Karolin, Trofimova, Tatyana, Borodulina, Elena, Jevtovic, Djordje, Bakowska, Elzbieta, Kase, Kerstin, Kyselyova, Galina, Haubrich, Richard, Rockstroh, Jürgen K, Peters, Lars

“…A hepatitis C (HCV) cure is associated with changes in lipids and inflammatory biomarkers, but its impact on clinical endpoints among treated human…”
Get full text

Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium by Bansi-Matharu, Loveleen, Phillips, Andrew, Oprea, Cristiana, Grabmeier-Pfistershammer, Katharina, Günthard, Huldrych F, De Wit, Stephane, Guaraldi, Giovanni, Vehreschild, Jorg J, Wit, Ferdinand, Law, Matthew, Wasmuth, Jan-Christian, Chkhartishvili, Nikoloz, d'Arminio Monforte, Antonella, Fontas, Eric, Vesterbacka, Jan, Miro, Jose M, Castagna, Antonella, Stephan, Christoph, Llibre, Josep M, Neesgaard, Bastian, Greenberg, Lauren, Smith, Colette, Kirk, Ole, Duvivier, Claudine, Dragovic, Gordana, Lundgren, Jens, Dedes, Nikos, Knudsen, Andreas, Gallant, Joel, Vannappagari, Vani, Peters, Lars, Elbirt, Daniel, Sarcletti, Mario, Braun, Dominique L, Necsoi, Coca, Mussini, Cristina, Muccini, Camilla, Bolokadze, Natalie, Hoy, Jennifer, Mocroft, Amanda, Ryom, Lene

“…Weight gain effects of individual antiretroviral drugs are not fully understood. We investigated associations between a prespecified clinically significant…”
Get full text

People who inject drugs remain hard-to-reach population across all HIV continuum stages in Central, Eastern and South Eastern Europe - data from Euro-guidelines in Central and Eastern Europe Network by Balayan, Tatevik, Oprea, Cristiana, Yurin, Oleg, Jevtovic, Djorde, Begovac, Josip, Lakatos, Botond, Sedlacek, Dalibor, Karpov, Igor, Horban, Andrzej, Kowalska, Justyna D.

“…Background/objectives: Inadequate HIV care for hard-to-reach populations may result in failing the UNAIDS 90-90-90 goal. Therefore, we aimed to review the HIV…”
Get full text

Euroguidelines in Central and Eastern Europe (ECEE) conference and the Warsaw Declaration – a comprehensive meeting report by Kowalska, JD, Oprea, C, Witt, S, Pozniak, A, Gökengin, D, Youle, M, Lundgren, JD, Horban, A, Balayan, T., Bednarska, A., Begovac, J., Bolokadze, N., Bukovinowa, P., Burkacka, E., Caplinskas, S., Cholewińska‐Szymańska, G., De Wit, S., Dragovic, G., Harxhi, A., Higersberger, J., Holban, T., Jevtovic, D., Jilich, D., Karpov, I., Konopnicki, D., Ladnaya, N., Lakatos, B., Marczyńska, M., Mardarescu, M., Otelea, D., Paciorek, M., Panteleev, A., Pietraszkiewicz, E., Podlasin, B., Podlekareva, D., Rukhadze, N., Ruutel, K., Skrzat‐Wojdacz, A., Streinu‐Cercel, A., Stańczak, J., Vassilenko, A., Yurin, O.

“…Objectives The objective of this paper is to summarize the outcomes of the Euroguidelines in Central and Eastern Europe (ECEE) conference held in Warsaw in…”
Get full text

Comparison of nucleoside reverse transcriptase inhibitor use as part of first-line therapy in a Serbian and a UK HIV clinic by Dragovic, G J, Smith, C J, Jevtovic, D J, Johnson, M A, Ranin, J, Salemovic, D, Youle, M S

“…Use of dideoxynucleoside reverse transcriptase inhibitors (dNRTIs) may lead to increased mitochondrial toxicity. We compared nucleoside reverse transcriptase…”
Get more information

Prediction of preeclampsia using extreme first-trimester PAPP-A, free βhCG and uterine artery Doppler in resource limited settings by Lukic, R., Djukic, M., Soldatovic, I., Orlic, N. Karadzov, Ardalic, D., Dragovic, G., Mikovic, Z.

Get full text

Risk of Liver Toxicity in HIV/HCV Coinfected Patients with Advanced Chronic Liver Disease Receiving Nevirapine (Viramune??) or Lopinavir/Ritonavir (Kaletra??) by Dragovic, G., Jevtovic, D.J.

Get full text

Prevalence of Hyperlactatemia in HIV-Infected Patients Taking Antiretroviral Drugs by Dragovic, G., Jevtovic, D.J.

Get full text

HIV health care providers are ready to introduce pre‐exposure prophylaxis in Central and Eastern Europe and neighbouring countries: data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group by Kowalska, JD, Bursa, D, Gökengin, D, Jilich, D, Tomazic, J, Vasylyev, M, Bukovinowa, P, Mulabdic, V, Antonyak, S, Horban, A, Alexiev, I., Afonina, L., Balayan, T., Bednarska, A., Begovac, J., Firląg‐Burkacka, E., Bolokadze, N., Caplinskas, S., Cholewińska‐Szymańska, G., Chkhartishvili, N., Witt, S., Dragovic, G., Harxhi, A., Higersberger, J., Holban, T., Jevtovic, D., Karpov, I., Konopnicky, D., Ladnaya, N., Lakatos, B., Lundgren, J.D., Mardarescu, M., Matłosz, B., Molina, J.M., Oprea, C., Otelea, D., Paciorek, M., Panteleev, A., Papadopoulos, A., Pietraszkiewicz, E., Podlasin, B., Podlekareva, D., Pozniak, A., Pula, J., Sedlacek, D., Skrzat‐Klapaczyńska, A., Simonović‐Babić, J., Sluzhynska, M., Streinu‐Cercel, A., Rukhadze, N., Ruutel, K., Stańczak, J., Vassilenko, A., Youle, M., Yurin, O., Zabłocka, H.

“…Objectives Pre‐exposure prophylaxis (PrEP) for HIV infection has been introduced in only a few European countries. We investigated the potential to provide…”
Get full text

Women in Serbia as late presenters‐an issue of concern by Dragovic, G, Ranin, J, Salemovic, D, Kusic, J, Jevtovic, D

“…Most of the clinical trials looking at the efficacy and side effects of highly active antiretroviral therapy (HAART) have been conducted primarily on…”
Get full text

State of viral hepatitis care in 16 countries of Central and Eastern European Region by Chkhartishvili, Nikoloz, Holban, Tiberiu, Simonović Babić, Jasmina, Alexiev, Ivailo, Matičič, Mojca, Kowalska, Justyna, Horban, Andrzej

“…Objectives: Survey was conducted to assess state of viral hepatitis care in Central and Eastern Europe (CEE). Methods: Representatives of 16 CEE countries…”
Get full text

An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes by Revell, Andrew D., Wang, Dechao, Wood, Robin, Morrow, Carl, Tempelman, Hugo, Hamers, Raph, Alvarez-Uria, Gerardo, Streinu-Cercel, Adrian, Ene, Luminita, Wensing, Annemarie, Reiss, Peter, van Sighem, Ard I., Nelson, Mark, Emery, Sean, Montaner, Julio S. G., Lane, H. Clifford, Larder, Brendan A.

“…Objectives The optimal individualized selection of antiretroviral drugs in resource-limited settings is challenging because of the limited availability of…”
Get full text

Patients infected with HIV/HCV and the liver injury as a side effect of HAART by Dragovic, G J, Jevtovic, D

Get full text

The prevalence and risk of hepatitis flares in a Serbian cohort of HIV and HCV co-infected patients treated with HAART : Human and animal retrovirruses by JEVTOVIC, Dj, RANIN, J, SALEMOVIC, D, PESIC, I, DRAGOVIC, G, ZERJAV, S, DJURKOVIC-DJAKOVIC, O

Get full text

Nucleoside Reverse Transcriptase Inhibitor Usage and the Incidence of Peripheral Neuropathy in HIV/AIDS Patients by Dragovic, Gordana, Jevtovic, Djordje

“…Peripheral neuropathy (PN) is a well-known adverse effect of treatment with nucleoside reverse transcriptase inhibitors (NRTIs). We performed a prospective…”
Get full text